Regional
Northwest Region Emergency Medical Services & Trauma Care Council
The current listed document is more than 24 months old and may be outdated.
Drugs and doses53
A–C Acetaminophen, Activated Charcoal, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Bumetanide, Calcium Chloride, Clopidogrel Bisulfate10
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 1000 mg | IV/PO/PR | not captured | standing | page 68 |
| Fever | peds | 15 mg/kg | IV/PO/PR | not captured | standing | page 68 |
| Mild to moderate pain | adult | 15 mg/kg | IV/PO | not captured | standing | pages 38, 151 |
| Mild to moderate pain | peds | 15 mg/kg | IV/PO | not captured | standing | pages 38, 151 |
| Sepsis | adult | 1000 mg | IV | not captured | standing | page 17 |
| Sepsis | peds | 15 mg/kg | IV | not captured | standing | page 17 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 50 g | PO | not captured | standing | page 152 |
| Other | adult | 50 g | PO | not captured | standing | page 152 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 152 |
| Other | peds | 1 g/kg | PO | not captured | standing | page 152 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV/IO | not captured | standing | pages 21, 22, 56 |
| SVT | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 21, 22, 56 |
| Narrow-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | pages 21, 56 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 21, 56 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 29, 63 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 63 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | pages 29, 63 |
| Asthma / bronchospasm | peds | 2.5–10 mg | NEB | not captured | standing | page 63 |
| Crush injury | adult | 5 mg | NEB | not captured | standing | pages 49, 66 |
| Crush injury | peds | 5 mg | NEB | not captured | standing | pages 49, 66 |
| Hyperkalemia | adult | 10 mg | NEB | not captured | standing | page 25 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 300 mg | IV/IO | not captured | standing | pages 23, 58 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | pages 23, 58 |
| Narrow-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 21, 56 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | pages 22, 57 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | pages 22, 57 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | pages 23, 58 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | pages 23, 58 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 325 mg | PO | not captured | standing | page 26 |
| ACS / chest pain | adult | 325 mg | PO | not captured | standing | page 26 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5–1 mg | IV | not captured | standing | pages 20, 55 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | pages 20, 55 |
| Organophosphate poisoning | adult | 2 mg | IV/IO | not captured | standing | pages 55, 66 |
| Organophosphate poisoning | peds | 0.08 mg/kg | IV/IO | not captured | standing | pages 55, 66 |
| Other | adult | 2–5 drop | IV | not captured | standing | page 16 |
| RSI induction | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 53 |
Bumetanide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 0.5–2 mg | IV/IO | not captured | standing | page 156 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 10–20 mg/kg | IV/IO | not captured | standing | page 156 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 10 mg/kg | IV/IO | not captured | standing | page 156 |
| Crush injury | adult | 10–20 mg/kg | IV/IO | not captured | standing | pages 49, 156 |
| Crush injury | peds | 10 mg/kg | IV/IO | not captured | standing | pages 49, 156 |
| Hyperkalemia | adult | 10–20 mg/kg | IV/IO | not captured | standing | page 156 |
| Hyperkalemia | adult | 1000 mg | IV | not captured | standing | page 25 |
| Hyperkalemia | peds | 10 mg/kg | IV/IO | not captured | standing | page 156 |
Clopidogrel Bisulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 300 mg | PO | not captured | standing | page 157 |
D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Epinephrine, Etomidate, Famotidine, Fentanyl, Furosemide10
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 61 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 61 |
| Asthma / bronchospasm | adult | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 29 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 29 |
| Croup | adult | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 63 |
| Croup | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 63 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 12.5–25 g | IV/IO | not captured | standing | pages 34, 158 |
| Hypoglycemia | peds | 0.5 g/kg | IV/IO | not captured | standing | pages 34, 158 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–5 mg | IV/IO/IM/IN | not captured | standing | pages 16, 26, 159 |
| Agitation | adult | 2–5 mg | IV/IO/IM | not captured | standing | pages 39, 159 |
| Agitation | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 39, 159 |
| Organophosphate poisoning | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 37, 159 |
| Mild to moderate pain | adult | 2–5 mg | IV/IO/IM/IN | not captured | standing | pages 38, 159 |
| Procedural sedation | adult | 2–5 mg | IV/IO/IM/IN | not captured | standing | pages 38, 159 |
| Seizure | adult | 5 mg | IV/IO/IM | not captured | standing | page 159 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 159 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 10–25 mg | IV/IO | not captured | standing | pages 21, 160 |
| Atrial fibrillation with RVR | adult | 10–25 mg | IV/IO | not captured | standing | pages 21, 160 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | PO | not captured | standing | page 33 |
| Allergic reaction | adult | 25–50 mg | IV/IM/PO | not captured | standing | page 33 |
| Allergic reaction | peds | 1 mg/kg | IV/IM/PO | not captured | standing | page 33 |
| Allergic reaction | peds | 25–50 mg | PO | not captured | standing | page 33 |
| Nausea / vomiting | adult | 25–50 mg | PO | not captured | standing | pages 32, 36 |
| Nausea / vomiting | peds | 25–50 mg | PO | not captured | standing | pages 32, 36 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | pages 33, 61 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | pages 33, 61 |
| Asthma / bronchospasm | adult | 0.1–0.3 mg | IM | not captured | standing | page 29 |
| Asthma / bronchospasm | adult | 0.3 mL | NEB | not captured | standing | page 29 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | pages 20, 55 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 20, 55 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 23, 24, 58, 59 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 23, 24, 58, 59 |
| Hypotension / shock | peds | 0.1–1.5 mcg/kg | IV/IO | not captured | standing | pages 17, 19, 31, 69 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.1–0.3 mg/kg | IV | not captured | standing | pages 53, 162 |
| RSI induction | peds | 0.1–0.3 mg/kg | IV | not captured | standing | pages 53, 162 |
Famotidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 20 mg | IV/IO | not captured | standing | pages 33, 163 |
| Allergic reaction | peds | 0.25 mg/kg | IV/IO | not captured | standing | pages 33, 163 |
| Anaphylaxis | adult | 20 mg | IV/IO | not captured | standing | pages 33, 61, 163 |
| Anaphylaxis | peds | 0.25 mg/kg | IV/IO | not captured | standing | pages 33, 61, 163 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 25 mcg | IV | not captured | standing | page 26 |
| Other | adult | 25 mcg | NEB | not captured | standing | page 16 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 38, 67, 163 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 38, 67, 163 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40–80 mg | IV | not captured | standing | pages 30, 164 |
| CHF / pulmonary edema | peds | 2 mg/kg | IV | not captured | standing | pages 30, 164 |
| Hyperkalemia | adult | 40 mg | IV | not captured | standing | page 25 |
G–L Glucagon, Heparin Sodium, Hydromorphone, Ipratropium, Ketamine, Ketorolac, Labetalol, Lidocaine, Lorazepam9
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 3–5 mg | IV/IM/IN | not captured | standing | pages 37, 164 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 3–5 mg | IV/IM/IN | not captured | standing | pages 37, 164 |
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | pages 34, 70, 164 |
| Hypoglycemia | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 34, 70, 164 |
Heparin Sodium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 60 unit/kg (max 4000 unit) | IV | not captured | standing | page 165 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.5 mg | IV | not captured | standing | page 166 |
| Mild to moderate pain | adult | 1–2 mg | IM | not captured | standing | page 166 |
| Mild to moderate pain | peds | 0.015 mg/kg | IV/IM | not captured | standing | page 166 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 167 |
| Asthma / bronchospasm | peds | 0.25 mg | NEB | not captured | standing | page 167 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 5–10 mg/kg | IM | not captured | standing | pages 167, 168 |
| Hyperactive delirium | peds | 5–10 mg/kg | IM | not captured | standing | pages 167, 168 |
| Mild to moderate pain | adult | 0.25 mg/kg | IV/IO | not captured | standing | pages 67, 167, 168 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 67, 167, 168 |
| Procedural sedation | adult | 0.5–2 mg/kg | IV/IO | not captured | standing | pages 167, 168 |
| Procedural sedation | peds | 0.5–2 mg/kg | IV/IO | not captured | standing | pages 167, 168 |
| RSI induction | adult | 1–2 mg/kg | IV | not captured | standing | pages 167, 168 |
| RSI induction | peds | 4–5 mg | IM | not captured | standing | pages 167, 168 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15 mg | IV | not captured | standing | page 169 |
| Other | adult | 30 mg | IM | not captured | standing | page 169 |
| Other | peds | 0.5 mg/kg | IV | not captured | standing | page 169 |
| Other | peds | 1 mg/kg | IM | not captured | standing | page 169 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 10–20 mg | IV | not captured | standing | pages 26, 170 |
| Other | adult | 10–20 mg | IV | not captured | standing | page 170 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–1 mg/kg | IV/IO | not captured | standing | page 171 |
| Wide-complex tachycardia | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 22, 171 |
| Wide-complex tachycardia | peds | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 22, 171 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 23, 58, 171 |
| VF / pulseless VT | peds | 1–1.5 mg/kg | IV/IO | not captured | standing | pages 23, 58, 171 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.5–4 mg | IV/IM/IN | not captured | standing | page 26 |
| Agitation | peds | 0.5–4 mg | IV/IO/IM/IN | not captured | standing | pages 39, 66, 172 |
| Other | adult | 0.5–4 mg | IV/IM/IN | not captured | standing | page 16 |
| Procedural sedation | adult | 0.5–2 mg | IV/IO/IM/IN | not captured | standing | pages 38, 67, 172 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 38, 67, 172 |
| Seizure | peds | 1–2 mg | IV/IO/IM/IN | not captured | standing | pages 70, 172 |
M–O Magnesium Sulfate, Methylprednisolone, Metoprolol, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oxymetazoline, Oxytocin11
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | pages 29, 63, 173 |
| Asthma / bronchospasm | peds | 25–50 mg/kg | IV | not captured | standing | pages 29, 63, 173 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV | not captured | standing | pages 42, 173 |
| Wide-complex tachycardia | adult | 2 g | IV | not captured | standing | pages 22, 173 |
| VF / pulseless VT | adult | 2 g | IV | not captured | standing | pages 23, 58, 173 |
| VF / pulseless VT | adult | 2 g | IV | not captured | standing | pages 23, 173 |
| VF / pulseless VT | peds | 50 mg/kg | IV | not captured | standing | pages 23, 58, 173 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IO/IM | not captured | standing | pages 33, 61, 174 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 33, 61, 174 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO/IM | not captured | standing | pages 29, 63, 174 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 29, 63, 174 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2.5–5 mg | IV | not captured | standing | pages 26, 175 |
| Atrial fibrillation with RVR | adult | 2.5–5 mg | IV | not captured | standing | pages 21, 175 |
| Atrial fibrillation with RVR | adult | 2.5–5 mg | IV | not captured | standing | pages 21, 175 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2.5–5 mg | IV/IM/IN | not captured | standing | pages 26, 176 |
| Agitation | adult | 2.5–5 mg | IV/IO/IM/IN | not captured | standing | pages 39, 66, 176 |
| Agitation | peds | 2.5–10 mg | IV/IO/IM/IN | not captured | standing | pages 39, 66, 176 |
| Other | adult | 2.5–5 mg | IV/IM/IN | not captured | standing | pages 16, 176 |
| Procedural sedation | adult | 2.5–5 mg | IV/IO/IM/IN | not captured | standing | pages 38, 67, 176 |
| Procedural sedation | peds | 2.5–5 mg | IV/IO/IM/IN | not captured | standing | pages 38, 67, 176 |
| RSI induction | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 93, 94, 176 |
| RSI induction | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 93, 94, 176 |
| Seizure | adult | 2.5–5 mg | IV/IO/IM/IN | not captured | standing | pages 40, 70, 176 |
| Seizure | peds | 5–10 mg | IV/IO/IM/IN | not captured | standing | pages 40, 70, 176 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2 mg | IV | not captured | standing | page 26 |
| Mild to moderate pain | adult | 0.1 mg/kg | IV/IM | not captured | standing | page 177 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 177 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–4 mg | IV/IO/IM/IN | not captured | standing | pages 37, 65, 177 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | pages 37, 65, 177 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 26, 30, 178 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | pages 30, 178 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 2–20 mcg | IV/IO | not captured | standing | pages 19, 31, 180 |
| Sepsis | adult | 2–20 mcg | IV/IO | not captured | standing | pages 17, 180 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4–8 mg | IV/IM/PO/SL | not captured | standing | pages 32, 36, 50, 67, 181 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/IM/PO/SL | not captured | standing | pages 32, 36, 50, 67, 181 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–3 puff | IN | not captured | standing | page 182 |
| RSI induction | adult | 2–3 puff | IN | not captured | standing | pages 92, 182 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 43 |
| Obstetric hemorrhage | adult | 20 unit | IV | not captured | standing | page 43 |
P–R Prednisone, Procainamide, Promethazine, Propofol, Rocuronium5
Prednisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 60 mg | PO | not captured | standing | pages 29, 183 |
| Asthma / bronchospasm | peds | 1–2 mg/kg | PO | not captured | standing | pages 29, 183 |
Procainamide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg/kg | IV | not captured | standing | page 21 |
| Other | adult | 20 mg/kg | IV | not captured | standing | page 22 |
| Other | adult | 4 mg/kg | IV | not captured | standing | pages 56, 57 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 6.25–12.5 mg | IV/IM | not captured | standing | pages 32, 36, 184 |
| Nausea / vomiting | peds | 6.25–12.5 mg | IV/IM | not captured | standing | pages 32, 36, 184 |
Propofol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 20–50 mg | IV | not captured | standing | page 185 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.6–1.2 mg/kg | IV | not captured | standing | pages 53, 57, 186 |
| RSI induction | peds | 0.6–1.2 mg/kg | IV | not captured | standing | pages 53, 57, 186 |
S–Z Sodium Bicarbonate, Succinylcholine, Tenecteplase, Thiamine, Ticagrelor, Tranexamic Acid, Vecuronium, Verapamil8
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asystole / PEA | adult | 1 mEq/kg | IV/IO | not captured | standing | page 24 |
| Asystole / PEA | peds | 1 mEq/kg | IV/IO | not captured | standing | page 24 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 24, 25, 49 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 24, 25, 49 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 24 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 24 |
| VF / pulseless VT | adult | 1 mEq/kg | IV/IO | not captured | standing | page 23 |
| VF / pulseless VT | peds | 1 mEq/kg | IV/IO | not captured | standing | page 23 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1.5 mg/kg | IV | not captured | standing | pages 93, 187 |
| RSI induction | peds | 2 mg/kg | IV | not captured | standing | pages 93, 187 |
Tenecteplase
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 30 mg | IV | not captured | standing | page 187 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV/IM | not captured | standing | page 188 |
| Other | adult | 100 mg | IV/IM | not captured | standing | page 188 |
| Other | adult | 100 mg | IV/IM | not captured | standing | page 188 |
| Other | adult | 100 mg | IV/IM | not captured | standing | page 34 |
| Seizure | adult | 100 mg | IV/IM | not captured | standing | page 188 |
Ticagrelor
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 180 mg | PO | not captured | standing | page 188 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 189 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | page 189 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 94, 191 |
| RSI induction | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 94, 191 |
Verapamil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 5 mg | IV/IO | not captured | standing | pages 21, 191 |
Cite this
Northwest Region Emergency Medical Services & Trauma Care Council, United States EMS Protocol Census. 197 dose entries, effective 2020-03-02.
https://protoquiz.com/census/agencies/northwest-region-emergency-medical-services-trauma-care-council/
The census is free and not for sale. Only public agencies are named.